Hypoglycemia risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{MAD}}
{{CMG}} {{AE}} {{MAD}}
==Overview==
==Overview==
Risk factors of hypoglycemia include diabetic patients with excessive insulin doses especially after missed meals or after exercise, nocturnal or with [[alcohol]]. Absolute endogenous [[insulin]] deficiency is another risk factor.
Risk factors of hypoglycemia include diabetic patients with excessive [[insulin]] doses especially after missed meals or after exercise, nocturnal or with [[alcohol]]. Absolute endogenous [[insulin]] deficiency is another risk factor.


==Risk Factors==
==Risk Factors==
 
Risk factors of hypoglycemia include:<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155  }}</ref><ref name="pmid12766131">{{cite journal| author=Cryer PE, Davis SN, Shamoon H| title=Hypoglycemia in diabetes. | journal=Diabetes Care | year= 2003 | volume= 26 | issue= 6 | pages= 1902-12 | pmid=12766131 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12766131  }}</ref>
=== Risk factors of hypoglycemia include:<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155  }}</ref> ===
* Excessive amounts of [[Insulin]] or [[insulin]]-inducing drugs, inappropriate timing or type of administration
* Excessive amounts of [[Insulin]] or insulin secretagogue doses, inappropriate timing of administration, or administration of the wrong type of drug.
* Decrease [[glucose]] intake (missed meals and overnight)
* Decrease exogenous [[glucose]] delivery (''e.g.'' after missed meals and during the overnight fast).
* Increased [[glucose]] need during exercise
* Increased [[glucose]] utilization (''e.g.'' during exercise).
* Decrease [[endogenous]] [[glucose]] production after [[alcohol]] intake
* Decrease endogenous glucose production (''e.g.'' after [[alcohol]] ingestion).
* [[Sensitivity]] to [[insulin]] is increased due to:
* Sensitivity to [[insulin]] is increased due to:
** Weight loss
** Weight loss
** Increase in regular exercise
** Improved [[glycemic control]]
** Improved glycemic control
** Physiologically in the middle of the night
** Physiologically in the middle of the night
* Decreased [[Insulin]] [[Clearance (medicine)|clearance]] due to [[renal failure]].
* [[renal failure]] due to decreased [[Insulin]] [[Clearance (medicine)|clearance]]


=== Risk factors for hypoglycemia-associated autonomic failure ===
=== Risk factors for hypoglycemia-associated autonomic failure ===
There are three defenses against hypoglycemia:
There are three defenses against hypoglycemia:<ref name="pmid12136392">{{cite journal| author=Cryer PE| title=Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. | journal=Diabetologia | year= 2002 | volume= 45 | issue= 7 | pages= 937-48 | pmid=12136392 | doi=10.1007/s00125-002-0822-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12136392  }}</ref>
* Decrease [[insulin]] levels in blood
* Decrease [[insulin]] levels in [[blood]]
* Increase glucagon production
* Increase [[glucagon]] production
* Increase [[epinephrine]] levels in body
* Increase [[epinephrine]] levels
Failure of any of these defenses increase chances of hypoglycemia. This occurs rapidly in [[Diabetes mellitus type 1|type 1 diabetes]] and more gradually in [[Diabetes mellitus type 2|type 2 diabetes]] mainly due to:<ref name="pmid19033403">{{cite journal| author=Cryer PE| title=The barrier of hypoglycemia in diabetes. | journal=Diabetes | year= 2008 | volume= 57 | issue= 12 | pages= 3169-76 | pmid=19033403 | doi=10.2337/db08-1084 | pmc=2584119 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19033403  }}</ref>
Failure of any of these defenses increase chances of hypoglycemia. This occurs rapidly in [[Diabetes mellitus type 1|type 1 diabetes]] and more gradually in [[Diabetes mellitus type 2|type 2 diabetes]] mainly due to:<ref name="pmid19033403">{{cite journal| author=Cryer PE| title=The barrier of hypoglycemia in diabetes. | journal=Diabetes | year= 2008 | volume= 57 | issue= 12 | pages= 3169-76 | pmid=19033403 | doi=10.2337/db08-1084 | pmc=2584119 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19033403  }}</ref>
* Absolute endogenous [[insulin]] deficiency
* Absolute endogenous [[insulin]] deficiency in [[Diabetes mellitus type 1|type1 DM]]
* A history of severe hypoglycemia, hypoglycemia unawareness, or both
* A history of severe hypoglycemia, hypoglycemia unawareness, or both
* Aggressive glycemic therapy (lower [[HbA1C]] levels, lower glycemic goals)
* Aggressive glycemic therapy (lower [[HbA1C]] levels, lower glycemic goals)

Revision as of 14:13, 2 October 2017

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia risk factors

CDC on Hypoglycemia risk factors

Hypoglycemia risk factors in the news

Blogs on Hypoglycemia risk factors

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

Risk factors of hypoglycemia include diabetic patients with excessive insulin doses especially after missed meals or after exercise, nocturnal or with alcohol. Absolute endogenous insulin deficiency is another risk factor.

Risk Factors

Risk factors of hypoglycemia include:[1][2]

Risk factors for hypoglycemia-associated autonomic failure

There are three defenses against hypoglycemia:[3]

Failure of any of these defenses increase chances of hypoglycemia. This occurs rapidly in type 1 diabetes and more gradually in type 2 diabetes mainly due to:[4]

  • Absolute endogenous insulin deficiency in type1 DM
  • A history of severe hypoglycemia, hypoglycemia unawareness, or both
  • Aggressive glycemic therapy (lower HbA1C levels, lower glycemic goals)

References

  1. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER; et al. (2009). "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 94 (3): 709–28. doi:10.1210/jc.2008-1410. PMID 19088155.
  2. Cryer PE, Davis SN, Shamoon H (2003). "Hypoglycemia in diabetes". Diabetes Care. 26 (6): 1902–12. PMID 12766131.
  3. Cryer PE (2002). "Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes". Diabetologia. 45 (7): 937–48. doi:10.1007/s00125-002-0822-9. PMID 12136392.
  4. Cryer PE (2008). "The barrier of hypoglycemia in diabetes". Diabetes. 57 (12): 3169–76. doi:10.2337/db08-1084. PMC 2584119. PMID 19033403.